Inovio Biomedical to Present at American Society of Gene Therapy Meeting
News May 31, 2007
Inovio Biomedical Corporation has announced that the company will make multiple presentations regarding its electroporation-mediated DNA delivery technology at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) being held in Seattle, WA, May 30 - June 3 at the Washington State Trade and Convention Center.
Inovio's DNA delivery systems are designed to enhance the potency of DNA-based immunotherapies and vaccines against infectious diseases and cancers.
Three of the five poster presentations discuss pre-clinical studies that evaluated immune responses to DNA vaccines directed against major infectious diseases including malaria, HIV and hepatitis C.
In all cases Inovio's electroporation technology enhanced antibody and cellular immune responses when compared with traditional vaccine delivery methods. Two other Inovio presentations report innovations in the development of electroporation DNA delivery devices.
These presentations include: Immunogenicity of a Cytokine Enhanced Multi-Antigen pDNA Vaccine with and without In Vivo Electroporation in Rhesus Macaques.
Largest Genetic Study of Osteoarthritis Advances ResearchNews
Osteoarthritis is a complex disease, and the genetic basis of the disease has proved difficult to pin down. A new study from the Sanger Institute provides much-needed hope.READ MORE
The DNA Shuffle: Barcoding Trick is Boost to RNA-SeqNews
SPLiT-seq is a new technology that can separate thousands of cells using innovative barcoding technology.READ MORE
Comments | 0 ADD COMMENT
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018